On his podcast, Andrew Huberman, MD, professor of neurobiology and ophthalmology at Stanford Universitys school of medicine, shared a potential, and slightly gory, origin story for BPC-157
When acetylcarnitine is injected directly into the brain, most of the acetyl groups were metabolized, as 60% of the injected acetylcarnitine was recovered as exhaled 14 CO 2 after 22 h, and the percentage recovered in the brain was 1.9, 1.6, 1.3, and 0.9% at 1, 3, 6, and 22 h, respectively [109]
Theres no way to verify whats actually in the vial, and no clinical accountability if something goes wrong
There is also evidence that glutathione infusions can reduce the risk of relapse and contribute to the regression of metastases or recurrences
These findings have never been reported before and deserve further investigations in larger populations
If you see any of these, discard the vial immediately